3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Neuroblastoma
4
Medulloblastoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Sarcoma
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Multiple Myeloma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Nuclear Medicine Department, Hospital
×
Clear all
No trials found.